LXEO — Lexeo Therapeutics, Inc. Common Stock · $147.7M cap

Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.

Use this LXEO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LXEO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LXEO SEC filings page. Lician reads the product cache first so this HTML stays unique to Lexeo Therapeutics, Inc. Common Stock even when a live quote feed is slow.

Lexeo Therapeutics, Inc. Common Stock latest statements (FY2025)

Latest cached year on this hub. Full LXEO income, balance, and cash tables.

  • Revenue$0
  • Net Income-$100.0M
  • Total Assets$268.7M
  • Total Debt$0
  • Free Cash Flow-$99.0M

LXEO recent filings